NZ605307A - Antibiotic formulations - Google Patents

Antibiotic formulations

Info

Publication number
NZ605307A
NZ605307A NZ605307A NZ60530711A NZ605307A NZ 605307 A NZ605307 A NZ 605307A NZ 605307 A NZ605307 A NZ 605307A NZ 60530711 A NZ60530711 A NZ 60530711A NZ 605307 A NZ605307 A NZ 605307A
Authority
NZ
New Zealand
Prior art keywords
suspension
disclosed
formulation
respiratory disease
acetate solvent
Prior art date
Application number
NZ605307A
Inventor
Fadil Al Alawi
Karthigeyan Nanjan
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Priority to NZ605307A priority Critical patent/NZ605307A/en
Publication of NZ605307A publication Critical patent/NZ605307A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

605307 Disclosed is a suspension formulation for administration to an animal, the suspension formulation including: at least one cephalosporin antibiotic or a pharmaceutically similar salt thereof; an oil; and a glycerol acetate solvent characterised in that the glycerol acetate solvent is included in the formulation in the range of 0.05 – 5% w/v. Also disclosed is a PET (polyethylene teraphthate) container comprising the suspension. The suspension is useful in treating or preventing bacterial infections such as bovine bacterial respiratory disease, swine bacterial respiratory disease, foot rot or metritis. Further disclosed is a method for preparing the suspension.
NZ605307A 2011-12-23 2011-12-23 Antibiotic formulations NZ605307A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ605307A NZ605307A (en) 2011-12-23 2011-12-23 Antibiotic formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ605307A NZ605307A (en) 2011-12-23 2011-12-23 Antibiotic formulations

Publications (1)

Publication Number Publication Date
NZ605307A true NZ605307A (en) 2014-05-30

Family

ID=58408268

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ605307A NZ605307A (en) 2011-12-23 2011-12-23 Antibiotic formulations

Country Status (1)

Country Link
NZ (1) NZ605307A (en)

Similar Documents

Publication Publication Date Title
MX2020000268A (en) Fxr receptor agonist.
MX2016009666A (en) Topical delivery of skin compositions having low ph.
BR112013003045A2 (en) compound and pharmaceutical composition and uses thereof, sterile container and method for preparing pharmaceutical composition for administration
WO2012032360A3 (en) Novel use
MY188825A (en) High-concentration monoclonal antibody formulations
WO2009087474A3 (en) Agonists for antimicrobial peptide systems
EP3312175A4 (en) Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition for preventing or treating diseases associated with pi3 kinases, containing same as active ingredient
PH12019500804A1 (en) Liposomal formulation for use in the treatment of cancer
BR112012021638A2 (en) pharmaceutical sterile optical preservative free composition in the form of a clear aqueous solution.
MX355843B (en) Spirocyclic isoxazoline parasiticidal combinations.
IN2014MN01470A (en)
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
EA201691490A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BRINZOLAMIDE
NZ702342A (en) Pharmaceutical formulation
MX364800B (en) Improved long-acting tilmicosin and use thereof in the treatment of bovine respiratory disease complex (brdc) and in the dry cow period.
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
SA112330457B1 (en) Phenyl-isoxazol derivatives and preparation process thereof
WO2014178789A9 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
WO2016137806A3 (en) Doses and methods of administering telavancin
MX2022001736A (en) Topical formulations and treatments.
NZ605307A (en) Antibiotic formulations
BR112014030288A2 (en) pharmaceutical composition
JOP20180071A1 (en) CJ Healthcare Corporation
MX2014007735A (en) Antibiotic formulations.
RU2014101995A (en) ANTI-PARASITIC COMPOSITION CONTAINING MACROCYCLIC LACTONE AND LEVAMIZOLE AND METHOD FOR TREATING PARASITIC INFESTATION

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 DEC 2017 BY JAMES + WELLS

Effective date: 20161205

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 DEC 2018 BY JAMES + WELLS

Effective date: 20171005

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 DEC 2019 BY JAMES + WELLS

Effective date: 20181011

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 DEC 2020 BY JAMES + WELLS

Effective date: 20190930

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 DEC 2021 BY JAMES + WELLS

Effective date: 20201006

ASS Change of ownership

Owner name: ELANCO NEW ZEALAND SIMPSON GRIERSON, NZ

Effective date: 20210707

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 DEC 2022 BY THOMSON REUTERS

Effective date: 20211207

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 DEC 2023 BY THOMSON REUTERS

Effective date: 20221102

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 DEC 2024 BY THOMSON REUTERS

Effective date: 20231101